{
    "Trade/Device Name(s)": [
        "ARCHITECT Tacrolimus Assay",
        "ARCHITECT Tacrolimus Calibrators"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K070820",
    "Predicate Device Reference 510(k) Number(s)": [
        "P970007"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MLM",
        "DLJ",
        "JIT"
    ],
    "Summary Letter Date": "July 18, 2007",
    "Summary Letter Received Date": "July 19, 2007",
    "Submission Date": "March 23, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1678",
        "21 CFR 862.3200",
        "21 CFR 862.1687"
    ],
    "Regulation Name(s)": [
        "Tacrolimus test system (special controls)"
    ],
    "Analyte Class(es)": [
        "tdm",
        "transplant",
        "chemistry"
    ],
    "Analyte(s)": [
        "Tacrolimus"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA Whole Blood Collection Tubes",
        "Transplant Pretreatment Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)",
        "Manual extraction",
        "Calibrator Curve"
    ],
    "Methodologies": [
        "Immunoassay",
        "Delayed one-step CMIA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent",
        "Extraction reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Tacrolimus Assay and Calibrators for quantitative determination of tacrolimus in whole blood using CMIA on the ARCHITECT i System",
    "Indications for Use Summary": "Quantitative determination of tacrolimus in human whole blood as an aid in management of liver and kidney allograft patients receiving tacrolimus therapy and for calibration of the ARCHITECT i System",
    "fda_folder": "Clinical Chemistry"
}